Skip to main content
Clinical Trials/NL-OMON21162
NL-OMON21162
Not yet recruiting
Not Applicable

Treatment of stage I non-small cell lung cancer: designing information for patient participation in decision making.

Not provided0 sites25 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Patients presenting with a stage I non-small cell lung cancer (NSCLC).Patienten met stadium I niet kleincellige longkanker.
Sponsor
Not provided
Enrollment
25
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Not provided

Eligibility Criteria

Inclusion Criteria

  • 1\. Adult patients with early stage lung cancer who are scheduled to undergo SABR treatment;
  • 2\. Written informed consent according to local medical ethical committee regulations.

Exclusion Criteria

  • 1\. Patients who are unable to speak and understand the Dutch or English language;
  • 2\. Patients who are unable to provide informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials